Schedule 13D ownership disclosure

ITEOS THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 46565G104

Event date: 2025-06-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 3,826,692.00 · Class: 9.99%

  • KEVIN TANGReported CIK 0001178579

    Shares: 3,826,692.00 · Class: 9.99%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 2,618,219.00 · Class: 6.84%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LPReported CIK 0002064011

    Shares: 1,208,473.00 · Class: 3.15%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-009148
Form type
SCHEDULE 13D
Filer
TANG CAPITAL MANAGEMENT LLC
CIK
CIK 1232621
Filed
Jun 12, 2025
Reporting period
Jun 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub